SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 47.82
-0.50 (-1.03%)
May 18, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Revenue
SMO ClinPlus CO.,LTD. had revenue of 194.03M CNY in the quarter ending March 31, 2026, with 9.95% growth. This brings the company's revenue in the last twelve months to 860.07M, up 8.09% year-over-year. In the year 2025, SMO ClinPlus CO.,LTD. had annual revenue of 842.50M with 4.82% growth.
Revenue (ttm)
860.07M
Revenue Growth
+8.09%
P/S Ratio
4.39
Revenue / Employee
201.37K
Employees
4,271
Market Cap
3.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 842.50M | 38.78M | 4.82% |
| Dec 31, 2024 | 803.73M | 43.69M | 5.75% |
| Dec 31, 2023 | 760.04M | 173.81M | 29.65% |
| Jan 1, 2023 | 586.23M | 83.27M | 16.55% |
| Dec 31, 2021 | 502.97M | 167.68M | 50.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.14B |
| Medicalsystem Biotechnology | 1.54B |
| Shanghai Labway Clinical Laboratory | 1.38B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.19B |
| Thalys Medical Technology Group | 971.32M |
| Berry Genomics Co.,Ltd | 922.27M |
| Guangdong Hybribio Biotech | 669.64M |